RedHill Biopharma reported $5.51M in Operating Expenses for its fiscal quarter ending in June of 2024.





Operating Expenses Change Date
Clal Biotechnology ILS 5.15M 9.47M Dec/2022
Compugen USD 9.78M 90K Sep/2025
Cronos Group USD -18.9M 56.74M Sep/2025
RedHill Biopharma USD 5.51M 1.08M Jun/2024